Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

Migraine is a common chronic neurologic disease that may affect nearly 1 billion people worldwide. Serotonin 5-HT1B and 5-HT1D receptor agonists (triptans) have been the most widely prescribed acute migraine treatments for decades. However, some patients who use triptans either do not have a…

Leave a Reply

Your email address will not be published. Required fields are marked *